“…Y. Kim et al, 2008), clorobiocin (Anderle et al, 2007), fortimicin (Dairi, Ohta, Hashimoto, & Hasegawa, 1992; Kuzuyama, Seki, Dairi, Hidaka, & Seto, 1995), thiostrepton (Kelly, Pan, & Li, 2009), chondrochloren (Rachid, Scharfe, Blocker, Weissman, & Muller, 2009), polytheonamide (Parent et al, 2016), cystobactamids (Baumann et al, 2014; Wang, Schnell, Baumann, Muller, & Begley, 2017), watasemycin (Inahashi et al, 2017), and bialaphos (Hidaka, Hidaka, Kuzuyama, & Seto, 1995; Kamigiri, Hidaka, Imai, Murakami, & Seto, 1992). However, mechanistic investigations of these enzymes have been limited, due in large part to their inherent insolubility upon overproduction in E. coli .…”